Co-founder and CEO of Biotia, Research Assistant Professor at SUNY Downstate Health Sciences University
BIOGRAPHY
Precision infectious disease discovery using next-generation sequencing and AI to provide insights into respiratory, urine, and stool samples
Presented at:
Microbiology Week Virtual Event Series 2020
Speaker
Abstract
Lessons around leveraging high-complexity next-generation sequencing tests for precision infectious disease discovery to guide patient treatment and improve health outcomes.
Learning Objectives:
1. Reviewing current available technology and limitations for microbial profiling
2. What is NGS and metagenomics
3. Applications of NGS in urine, stool, and respiratory samples and case studies